Abstract
This study aimed to determine whether mRNA expression of oncostatin-M (OSM) and its receptor (OSMR) in initial, pre-treatment intestinal biopsies is predictive of response to tumor necrosis factor antagonists (anti-TNF) in a pediatric inflammatory bowel disease (IBD) cohort. Secondary outcomes correlated OSM and OSMR expression with demographic variables; IBD type, extent, phenotype, and severity; laboratory values; and endoscopic findings. A retrospective chart review was conducted on 98 pediatric patients. Patients' clinical courses were stratified as follows: failed anti-TNF (n = 14), quiescent on anti-TNF (n = 36), anti-TNF naïve (n = 19), and age-matched non-IBD controls (n = 29). The mRNA from each patient's pre-treatment ileal or colonic biopsy was isolated, and expression of OSM and OSMR was analyzed. There was no difference in OSM or OSMR expression among the three IBD groups; however, expression was significantly higher in patients with IBD than non-IBD controls (P < 0.001). OSM and OSMR were more highly expressed in patients with ulcerative colitis (UC) with a Mayo score of 3 (P = 0.0092 and P = 0.0313, respectively). High OSM expression correlated with severe disease activity indices at diagnosis (P = 0.002), anemia...Continue Reading
References
Aug 8, 2007·Gastroenterology·Dan TurnerAnne M Griffiths
Feb 26, 2011·Inflammatory Bowel Diseases·Dan TurnerArie Levine
May 12, 2011·Inflammatory Bowel Diseases·Arie LevineJeffrey S Hyams
Jun 25, 2013·Autoimmunity Reviews·Shomron Ben-HorinYehuda Chowers
Apr 9, 2014·PloS One·Florian BeigelStephan Brand
Apr 25, 2014·BMC Gastroenterology·Satoshi YamadaHiroshi Nakase
May 27, 2014·Gastroenterology·Bruce E SandsStephen Hanauer
Aug 26, 2015·Alimentary Pharmacology & Therapeutics·A Marchal BressenotL Peyrin-Biroulet
Nov 6, 2015·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Bella UngarShomron Ben-Horin
Dec 14, 2016·The New England Journal of Medicine·Brian G FeaganUNKNOWN UNITI–IM-UNITI Study Group
Apr 4, 2017·Nature Medicine·Nathaniel R WestFiona Powrie
May 6, 2017·Nature Medicine·Walter M KimRichard S Blumberg
Jul 1, 2017·Tissue Barriers·Kathryn L Pothoven, Robert P Schleimer
Apr 6, 2018·Gut·Renaud GaujouxUNKNOWN Israeli IBD research Network (IIRN)
May 3, 2018·Inflammatory Bowel Diseases·Kristin E BurkeAshwin N Ananthakrishnan
Mar 23, 2019·Journal of Crohn's & Colitis·Huanyu ZhouMina Hassan-Zahraee
Sep 26, 2019·The New England Journal of Medicine·Bruce E SandsUNKNOWN UNIFI Study Group
Nov 2, 2019·Crohn's & Colitis 360·Phillip MinarLee A Denson
Nov 16, 2019·BMC Gastroenterology·Juha TaavelaJorma Isola
Jun 9, 2020·Alimentary Pharmacology & Therapeutics·Lorenzo BertaniCorrado Blandizzi